June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Age-Related Macular Degeneration prevalence in Portugal: the Coimbra Eye Study - Report 2
Author Affiliations & Notes
  • Rufino Silva
    Faculty of Medicine, University of Coimbra, Coimbra, Portugal
    Association for Innovation and Biomedical Research on Light, Coimbra, Portugal
  • Inês Laíns
    Faculty of Medicine, University of Coimbra, Coimbra, Portugal
    Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
  • Conceicao F Lobo
    Association for Innovation and Biomedical Research on Light, Coimbra, Portugal
    Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
  • João Figueira
    Association for Innovation and Biomedical Research on Light, Coimbra, Portugal
    Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
  • Luísa Ribeiro
    Association for Innovation and Biomedical Research on Light, Coimbra, Portugal
  • Sandrina Nunes
    Association for Innovation and Biomedical Research on Light, Coimbra, Portugal
  • Pedro Veiga
    Association for Innovation and Biomedical Research on Light, Coimbra, Portugal
  • Vitor Rodrigues
    Faculty of Medicine, University of Coimbra, Coimbra, Portugal
  • Maria Luz Cachulo
    Association for Innovation and Biomedical Research on Light, Coimbra, Portugal
    Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
  • Jose G Cunha-Vaz
    Faculty of Medicine, University of Coimbra, Coimbra, Portugal
    Association for Innovation and Biomedical Research on Light, Coimbra, Portugal
  • Footnotes
    Commercial Relationships Rufino Silva, Alcon (C), Alimera (C), Allergan (C), Bayer (C), Novartis (C), Thea (C); Inês Laíns, None; Conceicao Lobo, None; João Figueira, Alcon (C), Allergan (C), Bayer (C), Kemin (C), Novartis (C); Luísa Ribeiro, None; Sandrina Nunes, None; Pedro Veiga, None; Vitor Rodrigues, None; Maria Luz Cachulo, None; Jose Cunha-Vaz, Alimera Sciences (C), Allergan (C), Bayer (C), Gene Signal (C), Novartis (C), OM Pharma (C), Pfizer (C), Roche (C), Sanofi-Fovea (C), Zeiss (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3769. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rufino Silva, Inês Laíns, Conceicao F Lobo, João Figueira, Luísa Ribeiro, Sandrina Nunes, Pedro Veiga, Vitor Rodrigues, Maria Luz Cachulo, Jose G Cunha-Vaz; Age-Related Macular Degeneration prevalence in Portugal: the Coimbra Eye Study - Report 2. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3769.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The Coimbra Eye Study is the first population-based study on Age-Related Macular Degeneration (AMD) including Portuguese subjects. Besides being located in Southern Europe, Portugal presents distinct environmental characteristics that might influence AMD. After our first report about the prevalence of the disease in a coastal town, the aim of this second report was to include an inland town population in our prevalence estimates and two compare both.

Methods: Cross-sectional study, including two Portuguese populations aged ≥ 55 years: one from a coastal town and the second from an inland town. All participants were inquired about their past medical history and submitted to complete ophthalmological exam. Color fundus photographs were also obtained for AMD grading, which was performed using a semi-automated software by a certified reading center, according to the Rotterdam staging. Patients with poor dilation or poor quality images were excluded.

Results: Of the 6023 subjects enrolled, 99.55% were included in the analysis (2975 from the coastal town and 3021 from the inland village). This population was not representative of the age categories ≥ 75 years, so all analyses were weighted by age and gender. Eighty percent of the included subjects presented no signs of age-related maculopathy (ARM) (79.80%; 95%CI:78.77% - 80.83%), while 1.16% (95%CI:0.85%-1.43%) presented late AMD. ARM was significantly more prevalent in women (21.39%, 95% CI:19.96%-22.82%) than in men (18.67%, 95% CI:17.18%-20.16%; p=0.010), but no gender differences were found regarding AMD. Multivariate logistic regression revealed that older age (OR:1.04, p<0.001), other ophthalmological diseases (OR:2.17, p<0.001) and hypertension (OR = 1.16, p=0.037) were significant predictors of AMD. In the inland town, ARM (21.68%; 95% CI:20.21%-23.13%) and AMD (16.68%, 95% CI:15.35%-18.1%) were significantly more prevalent than in the coastal town (7.66%, 95% CI:6.70%-8.62% and 18.39%, 95% CI:16.99%-19.78% respectively, p≤ 0.001). The first presented a significantly higher proportion of smokers and ex-smokers (p<0.001).

Conclusions: The prevalence of late AMD in this Portuguese population was 1.16%, which is lower than most of what has been previously reported for other countries. In the included inland population the prevalence was significantly higher. Further analysis will be needed to completely unravel the underlying risks for this difference.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×